Athira Pharma
ATHA
ATHA
65 hedge funds and large institutions have $53.3M invested in Athira Pharma in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
7% less funds holding
Funds holding: 70 → 65 (-5)
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
65
Holding in Top 10
1
Calls
$840K
Puts
$14K
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.47M | |
| 3 | +$252K | |
| 4 |
PCM
Potomac Capital Management
New York
|
+$182K |
| 5 |
Morgan Stanley
New York
|
+$90K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$995K | |
| 3 | -$696K | |
| 4 |
Barclays
London,
United Kingdom
|
-$637K |
| 5 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$608K |